Land & Buildings Comments on Preliminary Results of National Health Investors Annual Meeting
STAMFORD, Conn.–(BUSINESS WIRE)–Land & Buildings Investment Management, LLC (together with its affiliates, “Land & Buildings”), a significant... Read more.
Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated... Read more.
AM Best Upgrades Credit Ratings of Fairfax Financial Holdings Limited, Its Subsidiaries and Allied World Assurance Company Holdings, Ltd.
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has upgraded the Long-Term Issuer Credit Rating (Long-Term ICR) to “a-” (Excellent) from “bbb+”... Read more.
EMD Serono Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 2025
Data from Phase 3 MANEUVER study demonstrating significant improvements in physical function and symptoms in patients with tenosynovial giant cell tumor (TGCT) treated... Read more.
CORRECTING and REPLACING Cyware Survey Reveals That 92% Believe Threat Intelligence Is Critical — But Most Organizations Still Struggle to Operationalize It
Cyware survey identifies significant gaps in internal collaboration, tool integration, and automation — with only 13% confident their systems currently work well... Read more.
Bitwise Announces Monthly Distributions for IMST, ICOI, and IMRA
SAN FRANCISCO–(BUSINESS WIRE)–Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option... Read more.
ARBA Retail Systems: Powering the Future of Retail with Artificial Intelligence
CHICAGO–(BUSINESS WIRE)–At ARBA Retail Systems, we’re leading the way in transforming retail technology with the power of AI and artificial intelligence.... Read more.
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
– Zanzalintinib in combination with nivolumab demonstrated an objective response rate of 63% and a disease control rate of 90% – – Additional results from... Read more.
KBRA Assigns Preliminary Ratings to BX 2025-LUNR
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA announces the assignment of preliminary ratings to four classes of BX 2025-LUNR, a CMBS single-borrower... Read more.
Erie’s Public Schools and Zurn Elkay Water Solutions Announce Donation for Cleaner, Healthier, Safer Drinking Water
This summer Erie’s Public Schools (EPS) will install 50 donated Elkay filtered bottle filling stations in nine elementary schools and convert all faucets at the... Read more.